Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- B5010 (R)-(-)-α-Methylhistamine dihydrobromide1 CitationSummary: Very potent, high affinity H3 agonist
- B5014 DPPE fumarateSummary: inhibitor of histamine binding at the intracellular histamine (Hlc) site
- B5016 2-CMDOSummary: Dopamine D2-like receptor antagonist
- B5021 TiotidineSummary: Potent histamine H2-receptor antagonist
- B5028 Dihydrexidine hydrochlorideSummary: dopamine D1 agonist
- B5043 L-745,870 trihydrochlorideSummary: highly potent and selective D4 dopamine receptor antagonist
- B5044 L-741,742 hydrochlorideSummary: highly potent and selective D4 dopamine receptor antagonist
- B5051 ACPT-ISummary: Agonist for group III mGlu receptors
- B5056 L-733,060 hydrochlorideSummary: Potent NK1 antagonist
- B6127 FenbufenSummary: COX inhibitor, non-steroidal anti-inflammatory drug